Liquiritin Attenuates Lipopolysaccharides-Induced Cardiomyocyte Injury via an AMP-Activated Protein Kinase-Dependent Signaling Pathway

• Váldodahkkit: Shan-Qi Mou (Dahkki), Zi-Ying Zhou (Dahkki), Hong Feng (Dahkki), Nan Zhang (Dahkki), Zheng Lin (Dahkki), Xiahenazi Aiyasiding (Dahkki), Wen-Jing Li (Dahkki), Wen Ding (Dahkki), Hai-Han Liao (Dahkki), Zhou-Yan Bian (Dahkki), Qi-Zhu Tang (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2021-05-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: Liquiritin (LIQ) is a traditional Chinese medicine that has been reported to regulate inflammation, oxidative stress and cell apoptosis. However, the beneficial effects of LIQ in lipopolysaccharides (LPS)-induced septic cardiomyopathy (SCM) has not been reported. The primary goal of this...